Agd Biomedicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 21-06-2024
- Paid Up Capital ₹ 1.00 Cr
as on 21-06-2024
- Company Age 28 Year, 15 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 19.87 Cr
as on 21-06-2024
- Satisfied Charges ₹ 6.60 M
as on 21-06-2024
- Revenue -4.48%
(FY 2023)
- Profit -55.65%
(FY 2023)
- Ebitda -40.75%
(FY 2023)
- Net Worth 11.68%
(FY 2023)
- Total Assets 22.61%
(FY 2023)
About Agd Biomedicals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹19.87 Cr. The company has closed loans amounting to ₹6.60 M, as per Ministry of Corporate Affairs (MCA) records.
Vivek Taskar, Nitin Deshmukh, Sejal Shah, and One other member serve as directors at the Company.
- CIN/LLPIN
U51397MH1996PTC104366
- Company No.
104366
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Dec 1996
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Agd Biomedicals Private Limited offer?
Agd Biomedicals Private Limited offers a wide range of products and services, including Hematology Analyzers, Cell Counter, IVDs & Analyzers, Clinical Reagents, Medical Laboratory Instruments, Hematology Reagents, Biochemistry Analyzer.
Who are the key members and board of directors at Agd Biomedicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashish Pradhan  | Managing Director | 06-Dec-1996 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nitin Deshmukh | Director | 11-Jan-2021 | Current |
| Vivek Taskar | Additional Director | 17-Oct-2017 | Current |
| Sejal Shah | Director | 06-Dec-1996 | Current |
Financial Performance of Agd Biomedicals.
Agd Biomedicals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.48% decrease. The company also saw a substantial fall in profitability, with a 55.65% decrease in profit. The company's net worth Soared by an impressive increase of 11.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Agd Biomedicals?
In 2023, Agd Biomedicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Jul 2021 | ₹4.00 M | Open |
Others Creation Date: 14 Aug 2018 | ₹1.00 Cr | Open |
The Saraswat Cooperative Bank Ltd Creation Date: 24 Sep 2015 | ₹5.00 M | Open |
How Many Employees Work at Agd Biomedicals?
Agd Biomedicals has a workforce of 27 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agd Biomedicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agd Biomedicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
